Clinical trial
G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)
NCT00255645
Study timeline
Study start (unknown)2005-09-01Date precision: month
Registry last updated2008-03-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Interventions
Sponsors & collaborators
AstraZenecalead sponsor
Mapped research locations
New YorkNew York, United States1HoustonTexas, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1MiamiFlorida, United States1TorontoOntario, Canada1San AntonioTexas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00255645 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.